Results 81 to 90 of about 111,297 (312)

Treatment With Propranolol for Infantile Hemangioma in 13 Taiwanese Newborns and Young Infants

open access: yesPediatrics and Neonatology, 2012
Hemangioma in infants has a benign self-limited course, but the 10% of cases with complications need further treatment. Successful treatment with propranolol in western countries has been reported over the past few years.
Teng-Chin Hsu   +6 more
doaj   +1 more source

Revisiting propranolol and PTSD: Memory erasure or extinction enhancement?

open access: yesNeurobiology of Learning and Memory, 2016
Posttraumatic stress disorder (PTSD) has been described as the only neuropsychiatric disorder with a known cause, yet effective behavioral and pharmacotherapies remain elusive for many afflicted individuals.
Thomas F. Giustino   +2 more
semanticscholar   +1 more source

Exocrine Gland Dysfunction in Parkinson's Disease: Pathophysiology, Clinical Manifestations, and Therapeutic Perspectives—A Narrative Review

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz   +2 more
wiley   +1 more source

Oral propranolol treatment safety in infantile hemangiomas

open access: yesJournal of Dermatological Treatment
Introduction Infantile hemangiomas are common and can be treated with propranolol. Cardiovascular side effects are a potential risk of propranolol treatment.
Sami Alsuwaidan   +3 more
doaj   +1 more source

Propranolol Is Associated with Lower Risk of Incidence of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Tertiary-Center Study and Indirect Comparison with Meta-Analysis

open access: yesGastroenterology Research and Practice, 2020
Alcoholic cirrhosis (AC) leads to enormous disease burden and occupies a substantial proportion in the etiology of hepatocellular carcinoma (HCC), but scarce attention has been paid to this topic.
Tzu-Hao Li   +13 more
doaj   +1 more source

Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study

open access: yesEBioMedicine, 2016
Background Angiosarcomas are rare malignant tumors of vascular origin that represent a genuine therapeutic challenge. Recently, the combination of metronomic chemotherapy and drug repositioning has been proposed as an attractive alternative for cancer ...
E. Pasquier   +10 more
semanticscholar   +1 more source

FXTAS and the Spectrum of FMR1 Premutation‐Associated Phenotypes in Latin America: A Scoping Review

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Fragile X–associated tremor/ataxia syndrome (FXTAS) is a late‐onset neurodegenerative disorder caused by FMR1 premutation expansions (55–200 CGG repeats). Although well described in populations of predominantly European ancestry, FXTAS remains poorly characterized in Latin America due to limited awareness, restricted access to ...
Amy Schmidmajer   +6 more
wiley   +1 more source

New onset bronchial asthma following oral propranolol for infantile hemangioma

open access: yesRespiratory Medicine Case Reports
Propranolol, a nonselective adrenergic beta-receptor blocker, is the first-line drug used for the treatment of infantile hemangiomas (IH). However, its use is contraindicated in patients with bronchial asthma.
Yuki Yamaguchi   +4 more
doaj   +1 more source

Propranolol in the Treatment of Infantile Hemangiomas

open access: yesClinical, Cosmetic and Investigational Dermatology, 2021
Xin Tan, Shu Guo, Chenchao Wang Department of Plastic Surgery, First Hospital of China Medical University, Shenyang, Liaoning Province, People’s Republic of ChinaCorrespondence: Chenchao WangDepartment of Plastic Surgery, First Hospital of China Medical ...
Tan X, Guo S, Wang C
doaj  

Effects of d,l-Propranolol, d-Propranolol, l-Propranolol, and Sotalol on Myocardial Contractility and Coronary Resistance

open access: yes, 1973
The effects of d,l-propranolol, d-propranolol, l-propranolol, and sotalol on myocardial contractility and vascular coronary resistance (V.C.R.) were studied on isolated perfused rat and guinea pig hearts, using a modified Langendorff technique.
G. M. Tremblay   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy